Natural Biocon (India) Ltd - 543207 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, Registrar and Transfer Agent of the Company for the quarter ended on 31st March, 2023. Natural Biocon (India) Ltd - 543207 - Closure of Trading Window
This is to inform that pursuant to the provisions of the Clause 4 (2) of Schedule B of Regulation 9 of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time) read with Company's code of conduct for regulating, monitoring and reporting of trading by insiders ('Insider Trading Code'), Trading window for the Promoters, KMP, Insiders; Designated and Connected persons closed from 01st April, 2023 till 48 (Forty-Eight) hours after the Financial Results of the Company for the Quarter and Financial Year ending on March 31, 2023 are approved by the Board of Directors and filed with stock exchanges. Natural Biocon (India) Ltd - 543207 - Outcome Of Meeting Of Independent Directors Held On March 24, 2023
A separate meeting of the Independent Directors of the Company for the Financial Year 2022-23 was held today, i.e., on Friday, 24th March, 2023 at the registered office of the company wherein the Independent Directors present at the meeting, inter-alia, transacted the following business: a) Reviewed the performance of non-independent directors and the board of directors as a whole; b) Reviewed the performance of the chairperson of the listed entity, taking into account the views of executive directors and non-executive directors; c) Assessed the quality, quantity and timeliness of flow of information between the management of the listed entity and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties Natural Biocon (India) Ltd - 543207 - Intimation Of Independent Directors Meeting To Be Held On 24Th March 2023
A Separate Meeting of the Independent Directors of Natural Biocon (India) Ltd. will be held on Friday, 24th March 2023 at the Registered Office of the Company to transact the following business: i. review the performance of Non-Independent Directors and the Board as whole. ii. review performance of the Chairperson of the Company. iii. access the Quantity, Quality and timeliness of flow of information. iv. Any other business with the permission of Chair. Natural Biocon (India) Ltd - 543207 - Outcome Of Board Meeting Dated 11.03.2023
With reference to above subject and in compliance Regulation 30 and any other applicable regulations of SEBI (LODR) 2015, we hereby submit the outcome of the Meeting of the Board of Directors held on 11th March 2023 at registered office of the company at 11:00 a.m. and concluded on 03:00 p.m.: - 1. Accepted and approved resignation of Ms. Birva Harshit Patel from the post of Company Secretary Cum Compliance Officer of the company. 2. Appointment of Mr. Gopal Trivedi as Company Secretary Cum Compliance Officer of the company. (Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with circular No. CIR/CFD/ CMD/4/2015 dated 9th September, 2015 are attached as Annexure-A). 3. Reviewed the other businesses of the company. Natural Biocon (India) Ltd - 543207 - Board Meeting Outcome for Outcome Of Board Meeting Dated 11.03.2023.
With reference to above subject and in compliance Regulation 30 and any other applicable regulations of SEBI (LODR) 2015, we hereby submit the outcome of the Meeting of the Board of Directors held on 11th March 2023 at registered office of the company at 11:00 a.m. and concluded on 03:00 p.m.: - 1. Accepted and approved resignation of Ms. Birva Harshit Patel from the post of Company Secretary Cum Compliance Officer of the company. 2. Appointment of Mr. Gopal Trivedi as Company Secretary Cum Compliance Officer of the company. (Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with circular No. CIR/CFD/ CMD/4/2015 dated 9th September, 2015 are attached as Annexure A). 3. Reviewed the other businesses of the company. Natural Biocon (India) Ltd - 543207 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On March 11, 2023.
Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2023 ,inter alia, to consider and approve 1. resignation of Ms. Birva Harshit Patel from the post of Company Secretary Cum Compliance Officer; and 2. appointment of Mr. Gopal Trivedi as Company Secretary Cum Compliance Officer; 3. any other business with the permission of chair Natural Biocon (India) Ltd - 543207 - Appointment Of Secretarial Auditor For The F.Y. 2022-23.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that Board of Directors of the Company has appointed CS Rupal Patel, Practising Company Secretary (Membership No. 6275, COP No. 3803) as Secretarial Auditor of the Company in pursuance to the provisions of the Section 204 of the Companies Act, 2013 and Regulation 24A of the Listing Regulations in their meeting held February 14th, 2023. Natural Biocon (India) Ltd - 543207 - Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2022 And Other Business.
1. Considered, adopted and approved Unaudited Financial Results for the quarter and nine months ended on 31st December, 2022 along with the Limited Review Report thereon. 2. Appointment of CS Rupal Patel as Secretarial Auditor of the company for the F.Y. 2022-23. 3. Reviewed the other business of the company. Natural Biocon (India) Ltd - 543207 - Financial Result For The Quarter And Nine Month Ended 31/12/2022.
Considered, adopted and approved Unaudited Financial Results for the quarter and nine months ended on 31st December, 2022 along with the Limited Review Report thereon.